Harvey E. Fries

424 total citations
12 papers, 158 citations indexed

About

Harvey E. Fries is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Harvey E. Fries has authored 12 papers receiving a total of 158 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Pharmacology. Recurrent topics in Harvey E. Fries's work include Synthesis and Biological Evaluation (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Harvey E. Fries is often cited by papers focused on Synthesis and Biological Evaluation (4 papers), Inflammatory mediators and NSAID effects (3 papers) and Metabolomics and Mass Spectrometry Studies (2 papers). Harvey E. Fries collaborates with scholars based in United States and United Kingdom. Harvey E. Fries's co-authors include Christopher A. Evans, Keith W. Ward, Richard M. Edwards, Peng Qi, Mali Jiang, Zhipeng Hou, James L. Ellis, George P. Vlasuk, Wenzhen Duan and Jiangyang Zhang and has published in prestigious journals such as Annals of the New York Academy of Sciences, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Harvey E. Fries

12 papers receiving 156 citations

Peers

Harvey E. Fries
Na-Young Choi South Korea
Bonnie Sturm United States
Gaowei Mao United States
Nayaab S Khan United States
Harvey E. Fries
Citations per year, relative to Harvey E. Fries Harvey E. Fries (= 1×) peers Daiki Hayashi

Countries citing papers authored by Harvey E. Fries

Since Specialization
Citations

This map shows the geographic impact of Harvey E. Fries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harvey E. Fries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harvey E. Fries more than expected).

Fields of papers citing papers by Harvey E. Fries

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harvey E. Fries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harvey E. Fries. The network helps show where Harvey E. Fries may publish in the future.

Co-authorship network of co-authors of Harvey E. Fries

This figure shows the co-authorship network connecting the top 25 collaborators of Harvey E. Fries. A scholar is included among the top collaborators of Harvey E. Fries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harvey E. Fries. Harvey E. Fries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Patterson, Jaclyn R., Alan P. Graves, Patrick Stoy, et al.. (2021). Identification of Diarylurea Inhibitors of the Cardiac-Specific Kinase TNNI3K by Designing Selectivity Against VEGFR2, p38α, and B-Raf. Journal of Medicinal Chemistry. 64(21). 15651–15670. 4 indexed citations
2.
Jiang, Mali, Peng Qi, Zhipeng Hou, et al.. (2014). Sirtuin 1 activator SRT2104 protects Huntington's disease mice. Annals of Clinical and Translational Neurology. 1(12). 1047–1052. 41 indexed citations
3.
Hilfiker, Mark A., Patrick M. Eidam, Ning Wang, et al.. (2011). Structure–activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 21(10). 2806–2811. 6 indexed citations
4.
Evans, Karen A., Dwight M. Morrow, Harvey E. Fries, et al.. (2010). 3-Urea-1-(phenylmethyl)-pyridones as novel, potent, and selective EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 20(22). 6744–6747. 6 indexed citations
5.
Hilfiker, Mark A., Ning Wang, Zhimin Du, et al.. (2009). Discovery of novel aminothiadiazole amides as selective EP3 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(15). 4292–4295. 15 indexed citations
6.
Hammond, Marlys, Jaclyn R. Patterson, Tram H. Hoang, et al.. (2009). Synthesis and SAR of amino acid-derived heterocyclic progesterone receptor full and partial agonists. Bioorganic & Medicinal Chemistry Letters. 19(10). 2637–2641. 10 indexed citations
7.
Behm, David J., Michael J. Neeb, Harvey E. Fries, et al.. (2008). Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues. British Journal of Pharmacology. 155(3). 374–386. 26 indexed citations
8.
Su, Xin, Erin S. R. Lashinger, Lisa A. Leon, et al.. (2008). An excitatory role for peripheral EP 3 receptors in bladder afferent function. American Journal of Physiology-Renal Physiology. 295(2). F585–F594. 28 indexed citations
10.
Fries, Harvey E., Christopher A. Evans, & Keith W. Ward. (2005). Evaluation of evaporative light-scattering detection for metabolite quantification without authentic analytical standards or radiolabel. Journal of Chromatography B. 819(2). 339–344. 10 indexed citations
11.
Evans, Christopher A., Harvey E. Fries, & Keith W. Ward. (2005). In vitro metabolic fate of a novel structural class: Evidence for the formation of a reactive intermediate on a benzothiophene moiety. Chemico-Biological Interactions. 152(1). 25–36. 4 indexed citations
12.
Troyer, Kevin P., et al.. (2002). Separating Vesicle Fusion and Exocytosis in Hypertonic Conditions. Annals of the New York Academy of Sciences. 971(1). 251–253. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026